Table 6.
Proinflammatory cytokine levels of the shikonin-treated group and dexamethasone-treated group (n = 6).
| Shikonin | Dexamethasone | p value | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| IL-4 | 0.33 | ±0.36 | 0.26 | ±0.14 | 0.465 |
| IL-5 | 0.90 | ±1.09 | 0.44 | ±1.08 | 0.068 |
| IL-6 | 0.74 | ±0.73 | 0.75 | ±0.66 | 1.000 |
| IL-9 | 5.26 | ±5.31 | 21.90 | ±17.35 | 0.046∗ |
| IL-13 | 1.23 | ±1.46 | 3.63 | ±4.52 | 0.075 |
| IL-17A | 5.53 | ±2.56 | 6.73 | ±4.12 | 0.249 |
| MCP-1 | 15.58 | ±14.45 | 32.52 | ±37.89 | 0.116 |
| MIP-1α | 9.91 | ±6.72 | 21.77 | ±25.23 | 0.463 |
| MIP-1β | 6.92 | ±7.17 | 147.70 | ±173.91 | 0.046∗ |
| RANTES | 3.60 | ±2.03 | 8.23 | ±5.97 | 0.043∗ |
Data are expressed as the mean ± standard deviation (SD). Data were analyzed using the Wilcoxon signed-rank test.